Windlas Biotech Limited

NSE:WINDLAS.NS

859.85 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income 169.93150.98140.31120.65114.4491.88121.9498147.8883.148366.8758.96122.8294.38-117.824.63
Depreciation & Amortization 033.8933.331.8935.6831.3529.050000032.6929.310023.8
Deferred Income Tax 00000000000000000
Stock Based Compensation 000010.080004.554.820000000
Change In Working Capital 000000000000212.65-261.700-59.11
Accounts Receivables 000000000000147.34-188.5300119.92
Change In Inventory 00000000000053.1-17.0200-181.55
Change In Accounts Payables 00000000000000000
Other Working Capital 00000000000012.21-56.15002.52
Other Non Cash Items -169.93-150.98-140.31-120.65-124.52-91.88-121.94-98-152.43-87.96-83-66.87-355.2527-94.38117.820.29
Operating Cash Flow 067.7866.663.7810.0862.758.104.554.8200-50.95-82.5700-30.39
Investing Activities:
Investments In Property Plant And Equipment 000000000000-9.85-21.8400-39.75
Acquisitions Net 00000000000000000
Purchases Of Investments 00000000000000000
Sales Maturities Of Investments 00000000000000000
Other Investing Activites 000000000000118.2638.200159.28
Investing Cash Flow 000000000000108.4116.3600119.53
Financing Activities:
Debt Repayment 000000000000-5.3-40.8500-13.47
Common Stock Issued 00000000000000000
Common Stock Repurchased 00000000000000000
Dividends Paid 00000000000000000
Other Financing Activities 00000000000078.43108.910074.19
Financing Cash Flow 00000000000073.1368.060060.72
Other Information:
Effect Of Forex Changes On Cash 0000000000000.0126.850030.92
Net Change In Cash 067.7866.663.7810.0862.758.104.554.8200130.628.700180.78
Cash At End Of Period 0342.06274.28100.6436.861,067.541,004.8404.554.820159.3159.328.70180.78180.78